首页> 外文期刊>Cytometry, Part A: the journal of the International Society for Analytical Cytology >The number of circulating endothelial cells is not increased in systemic sclerosis and related disorders: assessment of the pathogenetic role played by cxcr4(pos) progenitor cells coexpressing monocytic and endothelial markers
【24h】

The number of circulating endothelial cells is not increased in systemic sclerosis and related disorders: assessment of the pathogenetic role played by cxcr4(pos) progenitor cells coexpressing monocytic and endothelial markers

机译:在系统性硬化症和相关疾病中循环内皮细胞的数量没有增加:共同表达单核细胞和内皮标记物的cxcr4(pos)祖细胞的致病作用评估

获取原文
获取原文并翻译 | 示例
           

摘要

There are ongoing controversies regarding the role of circulating endothelial mature and progenitor cells (CECs/CEPs) in the pathogenesis of the systemic sclerosis (SSc). Circulating hematopoietic and/or endothelial progenitor cells, possibly implicated in the pathogenesis of SSc, were characterized and enumerated by a multiparametric 4-color flow cytometric protocol, in combination with different progenitor cell replating assays, in peripheral blood specimens obtained from 40 patients with SSc, various autoimmune diseases, and controls. Data were compared with patient’s clinical features and serum levels of angiogenic factors.
机译:关于循环内皮成熟细胞和祖细胞(CEC / CEP)在系统性硬化症(SSc)发病机理中的作用,目前存在争议。通过多参数4色流式细胞术方案结合不同的祖细胞重铺测定法,对从40例SSc患者中获得的外周血标本进行了特征化和计数,可能与SSc的发病机理相关联,对循环造血和/或内皮祖细胞进行了表征和枚举,各种自身免疫性疾病和对照。将数据与患者的临床特征和血清血管生成因子水平进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号